-
公开(公告)号:US09782368B2
公开(公告)日:2017-10-10
申请号:US15129654
申请日:2015-03-31
Applicant: EMERAMED LIMITED
Inventor: Boyd Eugene Haley , Ragnar Axel Theodor Klingberg
IPC: A61K31/166 , A61K45/06
CPC classification number: A61K31/166 , A61K45/06
Abstract: According to the invention there is provided N,N-bis-2-mercaptoethyl isophthalamide, or a pharmaceutically acceptable salt or derivative thereof, for use in regenerating ascorbate systemically and thus in the therapeutic treatment of chronic obstructive pulmonary disease.
-
公开(公告)号:US11628151B2
公开(公告)日:2023-04-18
申请号:US17953622
申请日:2022-09-27
Applicant: EMERAMED LIMITED
Inventor: Boyd Eugene Haley , Ragnar Axel Theodor Klingberg
IPC: A61K31/166 , A61P25/28 , A61K45/06 , A61K31/428 , A61K31/13 , A61K31/198 , A61K31/4745 , A61K31/165
Abstract: According to the invention there is provided N,N-bis-2-mercaptoethyl isophthalamide, or a pharmaceutically acceptable salt or derivative thereof, for use in the therapeutic treatment of a neurodegenerative disorder, such as Alzheimer's disease, Parkinson's disease, Huntington's disease and/or amyotrophic lateral sclerosis.
-
公开(公告)号:US12128017B2
公开(公告)日:2024-10-29
申请号:US17558975
申请日:2021-12-22
Applicant: EMERAMED LIMITED
Inventor: Boyd Eugene Haley , Ragnar Axel Theodor Klingberg
IPC: A61K31/166 , A61K31/13 , A61K31/165 , A61K31/198 , A61K31/428 , A61K31/4745 , A61K45/06 , A61P25/28
CPC classification number: A61K31/166 , A61K31/13 , A61K31/165 , A61K31/198 , A61K31/428 , A61K31/4745 , A61K45/06 , A61P25/28 , Y02A50/30 , A61K31/13 , A61K2300/00 , A61K31/165 , A61K2300/00 , A61K31/166 , A61K2300/00 , A61K31/428 , A61K2300/00 , A61K31/4745 , A61K2300/00 , A61K31/198 , A61K2300/00
Abstract: According to the invention there is provided N,N-bis-2-mercaptoethyl isophthalamide, or a pharmaceutically acceptable salt or derivative thereof, for use in the therapeutic treatment of a neurodegenerative disorder, such as Alzheimer's disease, Parkinson's disease, Huntington's disease and/or amyotrophic lateral sclerosis.
-
-